The role of oxidative stress in atherosclerosis progression in patients with coronary heart disease combined with chronic obstructive pulmonary disease

被引:0
|
作者
Grigorieva, N. Yu. [1 ]
Kuznetsov, A. N. [1 ]
Sharabrin, E. G. [2 ]
Kontorstchikova, K. N. [3 ]
Korolyova, E. F. [3 ]
机构
[1] Nizhny Novgorod State Med Acad, Dept Dept & Outpatient Therapy, Nizhnii Novgorod, Russia
[2] Nizhny Novgorod State Med Acad, Dept Radiodiag & Radiotherapy, Nizhnii Novgorod, Russia
[3] Nizhny Novgorod State Med Acad, Dept Clin Lab Diag, Nizhnii Novgorod, Russia
关键词
chronic obstructive pulmonary disease; coronary heart disease; stable angina pectoris; lipid peroxidation; oxidative stress;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the study is to specify the condition of "oxidants-antioxidants" system in patients with coronary heart disease (stable angina pectoris) combined with chronic obstructive pulmonary disease (COPD) so as to assess the activity of a pathological process underlying atherosclerosis progression. Materials and Methods. 389 patients were examined. The 1st group consisted of the patients with stable angina pectoris combined with COPD. The patients with stable angina pectoris were included into the 2nd (control) group. And in the 3rd (control) group there were patients with COPD. Results. Maximum alterations of all lipid peroxidation indexes were revealed in the combination of stable angina pectoris and COPD. The amounts of primary lipid peroxidation products - diene and triene conjugates (DC and TC) - in the patients of the 1st and the 3rd groups were reduced but did not differ between themselves (DC, p=0.9; TC, p=0.6); and the amount of final lipid peroxidation products - Schiff bases (SB) - in 1st group patients appeared to be statistically significant more than that in 3rd group patients (p=0.006). The amount of DC, TC and SB exceeded the norm in 2nd group patients but was lower than that in the 1st group (p<0.05) and the 3rd group (p<0.05). Conclusion. In patients with coronary heart disease combined with COPD there is observed the intensification (potentiation) of pathological reaction resulting in a marked oxidative stress development. Thus, it can be concluded that lipid exchange imbalance and clinical manifestations of coronary heart disease with COPD will occur earlier than in the absence of COPD, and be severe.
引用
收藏
页码:69 / 72
页数:4
相关论文
共 50 条
  • [1] Osteopontin as a marker of pulmonary hypertension in patients with coronary heart disease combined with chronic obstructive pulmonary disease
    Hetman, O.
    Krakhmalova, O.
    CARDIOVASCULAR RESEARCH, 2016, 111 : S113 - S114
  • [2] The β-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
    Abdullayev, Vasif
    Aliyeva, Gulzar
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease
    Grigoryeva, N. Yu.
    Kuznetsov, A. N.
    Koroleva, T. V.
    Koroleva, M. E.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (08) : 91 - +
  • [4] Effects of chronic obstructive pulmonary disease on coronary atherosclerosis
    Ramazan Topsakal
    Nihat Kalay
    Ibrahim Ozdogru
    Yakup Cetinkaya
    Sema Oymak
    Mehmet Gungor Kaya
    Ali Dogan
    Mehmet Tugrul Inanc
    Ali Ergin
    Heart and Vessels, 2009, 24 : 164 - 168
  • [5] Effects of chronic obstructive pulmonary disease on coronary atherosclerosis
    Topsakal, Ramazan
    Kalay, Nihat
    Ozdogru, Ibrahim
    Cetinkaya, Yakup
    Oymak, Sema
    Kaya, Mehmet Gungor
    Dogan, Ali
    Inanc, Mehmet Tugrul
    Ergin, Ali
    HEART AND VESSELS, 2009, 24 (03) : 164 - 168
  • [6] Oxidative Stress in Chronic Obstructive Pulmonary Disease
    Barnes, Peter J.
    ANTIOXIDANTS, 2022, 11 (05)
  • [7] Oxidative stress in chronic obstructive pulmonary disease
    Repine, JE
    Bast, A
    Lankhorst, I
    deBacker, W
    Dekhuijzen, R
    Demedts, M
    vanHerwaarden, C
    vanKlaveren, R
    Lammers, JW
    Larsson, S
    Lundback, B
    Petruzelli, S
    Postma, D
    Riise, G
    Vermeire, P
    Wouters, E
    Yernault, JC
    vanZandwijk, N
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (02) : 341 - 357
  • [8] Chronic obstructive pulmonary disease and oxidative stress
    Domej, W.
    Foeldes-Papp, Z.
    Floegel, E.
    Haditsch, B.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (02) : 117 - 123
  • [9] Ivabradine therapy in patients with coronary heart disease and chronic obstructive pulmonary disease
    Zheleznyakova, N. A.
    Sokolov, I. M.
    Gafanovich, E. Ya.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2012, (01): : 70 - 74
  • [10] The phenotypes of chronic heart failure in patients with ischemic heart disease combined with chronic obstructive pulmonary disease
    Potabashniy, V. A.
    MEDICAL PERSPECTIVES-MEDICNI PERSPEKTIVI, 2018, 23 (03): : 161 - 171